Suppr超能文献

部分水解婴儿配方奶粉与两种深度水解配方奶粉预防过敏的比较:一项前瞻性随机研究。

Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study.

作者信息

Halken S, Hansen K S, Jacobsen H P, Estmann A, Faelling A E, Hansen L G, Kier S R, Lassen K, Lintrup M, Mortensen S, Ibsen K K, Osterballe O, Høst A

机构信息

Department of Paediatrics at Sønderborg Hospital, Denmark.

出版信息

Pediatr Allergy Immunol. 2000 Aug;11(3):149-61. doi: 10.1034/j.1399-3038.2000.00081.x.

Abstract

The aim of this study was to compare the allergy-preventive effect of a partially hydrolyzed formula with two extensively hydrolyzed formulas, in infants with a high risk for development of allergic disease. High-risk infants from four Danish centres were included in the period from June 1994 to July 1995. Five-hundred and ninety-five high-risk infants were identified. High-risk infants were defined as having biparental atopy, or a single atopic first-degree relative combined with cord blood immunoglobulin E (IgE)> or =0.3 kU/l. At birth all infants were randomized to one of three different blinded formulas. All mothers had unrestricted diets during pregnancy and lactation and were encouraged to breast-feed exclusively. If breast-feeding was insufficient, one of the three formulas, according to randomization, was given during the first 4 months. It was recommended not to introduce cow's milk, cow's milk products. and solid foods until the age of 4 months. After the age of 4 months a normal unrestricted diet and conventional cow's milk-based formula were given when needed. All infants were followed-up prospectively with interview and physical examination at the age of 6, 12, and 18 months, and if any possible atopic symptoms were reported. If food allergy was suspected, controlled elimination/challenge procedures were performed in a hospital setting. Of 550 infants included in the study, 514 were seen at all visits and 36 were excluded owing to noncompliance. Of 478 infants who completed the study, 232 were exclusively breast-fed, 79 received an extensively hydrolyzed casein formula (Nutramigen), 82 an extensively hydrolyzed whey formula (Profylac), and 85 a partially hydrolyzed whey formula (Nan HA), during the first 4 months of life. These four groups were identical in regard to atopic predisposition, cord blood IgE, birthplace, and gender. Exclusively breast-fed children were exposed less to tobacco smoke and pets at home and belonged to higher social classes, whereas the three formula groups were identical concerning environmental factors. The frequency of breast-feeding was high; only eight (2%) children were not breast-fed at all. The three formula groups were identical in regard to duration of breast-feeding and age at introduction of formula and solid foods. No significant differences were found in the three groups of infants receiving formula milk regarding the cumulative incidence of atopic dermatitis or respiratory symptoms. The cumulative incidence of parental-reported cow's milk allergy was significantly higher in children fed partially hydrolyzed formula (Nan HA) compared with extensively hydrolyzed formula (Nutramigen or Profylac) at 12 and 18 months (NanHA, 7.1%; Nutramigen, 2.5%; Profylac, 0%; p=0.033). The cumulative incidence of confirmed cow's milk allergy was 1.3% (three of 232) in exclusively breast-fed infants, 0.6% (one of 161) in infants fed extensively hydrolyzed formula (Nutramigen or Profylac), and 4.7%(four of 85) in infants fed partially hydrolyzed formula (Nan HA). Partially hydrolyzed formula was found to be less effective than extensively hydrolyzed formula in preventing cow's milk allergy, 0.6% vs. 4.7% (p=0.05), but because of the small number of cases the results should be interpreted with caution. Compared with other similar studies the frequency ofatopic symptoms was low, even though the dietetic intervention did not include either maternal diet during lactation or dietary restrictions to the children after the age of 4 months.

摘要

本研究旨在比较部分水解配方奶粉与两种深度水解配方奶粉对过敏性疾病高危婴儿的过敏预防效果。1994年6月至1995年7月期间,纳入了来自丹麦四个中心的高危婴儿。共识别出595名高危婴儿。高危婴儿的定义为双亲患有特应性疾病,或有一位患特应性疾病的一级亲属且脐血免疫球蛋白E(IgE)≥0.3 kU/l。所有婴儿在出生时被随机分配至三种不同的盲法配方奶粉之一。所有母亲在孕期和哺乳期饮食不受限制,并鼓励纯母乳喂养。如果母乳喂养不足,根据随机分组情况,在头4个月给予三种配方奶粉之一。建议在4个月龄前不引入牛奶、奶制品和固体食物。4个月龄后,根据需要给予正常的无限制饮食和传统的以牛奶为基础的配方奶粉。所有婴儿在6、12和18个月龄时进行前瞻性随访,通过访谈和体格检查,若有任何可能的特应性症状则进行报告。如果怀疑食物过敏,则在医院环境中进行控制性排除/激发试验。在纳入研究的550名婴儿中,有514名完成了所有访视,36名因不依从被排除。在完成研究的478名婴儿中,232名纯母乳喂养,79名在生命的头4个月接受深度水解酪蛋白配方奶粉(纽康特),82名接受深度水解乳清蛋白配方奶粉(普瑞米尔),85名接受部分水解乳清蛋白配方奶粉(能恩HA)。这四组在特应性易感性、脐血IgE、出生地和性别方面相同。纯母乳喂养的儿童在家中接触烟草烟雾和宠物较少,且属于较高社会阶层,而三个配方奶粉组在环境因素方面相同。母乳喂养频率较高;只有8名(2%)儿童完全没有进行母乳喂养。三个配方奶粉组在母乳喂养持续时间、引入配方奶粉和固体食物的年龄方面相同。在接受配方奶粉喂养的三组婴儿中,特应性皮炎或呼吸道症状的累积发病率没有显著差异。在12和18个月时,与深度水解配方奶粉(纽康特或普瑞米尔)相比,接受部分水解配方奶粉(能恩HA)喂养的儿童中,家长报告的牛奶过敏累积发病率显著更高(能恩HA,7.1%;纽康特,2.5%;普瑞米尔,0%;p = 0.033)。纯母乳喂养婴儿中确诊牛奶过敏的累积发病率为1.3%(232名中有3名),接受深度水解配方奶粉(纽康特或普瑞米尔)喂养的婴儿中为0.6%(161名中有1名),接受部分水解配方奶粉(能恩HA)喂养的婴儿中为4.7%(85名中有4名)。发现部分水解配方奶粉在预防牛奶过敏方面不如深度水解配方奶粉有效,分别为0.6%和4.7%(p = 0.05),但由于病例数较少,结果应谨慎解释。与其他类似研究相比,尽管饮食干预不包括哺乳期母亲的饮食或4个月龄后儿童的饮食限制,但特应性症状的发生率较低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验